
IPHA vs VIR
$IPHA vs $VIR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
IPHA vs VIR: the quick read
- ·VIR is the larger company by market cap ($2.34B vs $169M).
- ·VIR has been more active on our scanner (119 vs 1 alerts in 30 days).
- ·IPHA has the smaller float (96.7M vs 154.7M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·IPHA trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·VIR draws far more of our scanner's attention, 119 unusual-volume alerts in 30 days against 1, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: VIR is more than 14x the market cap of IPHA, so the same dollar of news moves IPHA far harder.
- ·They have diverged badly over the year: VIR is near the top of its 52-week range while IPHA is near the bottom of its own.
- ·VIR pays a dividend and IPHA does not, which usually means one is being held for income and the other for the move.
- ·VIR is the one in play today, trading about 3.8x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Watching IPHA or VIR? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing IPHA and VIR on TheDesperateTrader.
- Is IPHA or VIR the better stock?
- "Better" depends on your goal, and these two are not alike. VIR is the larger company by market cap ($2.34B vs $169M). VIR has been more active on our scanner (119 vs 1 alerts in 30 days). IPHA has the smaller float (96.7M vs 154.7M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between IPHA and VIR?
- The differences that matter: VIR is roughly 14x the size of the other by market cap ($169M vs $2.34B); they trade at very different share prices ($1.48 vs $13.50); IPHA sits at 20% of its 52-week range against 90% for VIR; only VIR pays a dividend; our scanner flagged IPHA 1 times in the last 30 days against 119 for VIR. Everything above is measured from the latest completed session and SEC filings.
- Which of IPHA and VIR is more active right now?
- Right now IPHA is at about 0.6x its normal volume and VIR is at about 3.8x, so VIR is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading IPHA or VIR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore IPHA and VIR comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.